Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 212038

Expand all

ADHANSIA XR (METHYLPHENIDATE HYDROCHLORIDE)
25MG Marketing Status: Prescription

Active Ingredient: METHYLPHENIDATE HYDROCHLORIDE
Proprietary Name: ADHANSIA XR
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 25MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N212038
Product Number: 001
Approval Date: Feb 27, 2019
Applicant Holder Full Name: PURDUE PHARMA LP
Marketing Status:  Prescription
Patent and Exclusivity Information

ADHANSIA XR (METHYLPHENIDATE HYDROCHLORIDE)
35MG Marketing Status: Prescription

Active Ingredient: METHYLPHENIDATE HYDROCHLORIDE
Proprietary Name: ADHANSIA XR
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 35MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N212038
Product Number: 002
Approval Date: Feb 27, 2019
Applicant Holder Full Name: PURDUE PHARMA LP
Marketing Status:  Prescription
Patent and Exclusivity Information

ADHANSIA XR (METHYLPHENIDATE HYDROCHLORIDE)
45MG Marketing Status: Prescription

Active Ingredient: METHYLPHENIDATE HYDROCHLORIDE
Proprietary Name: ADHANSIA XR
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 45MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N212038
Product Number: 003
Approval Date: Feb 27, 2019
Applicant Holder Full Name: PURDUE PHARMA LP
Marketing Status:  Prescription
Patent and Exclusivity Information

ADHANSIA XR (METHYLPHENIDATE HYDROCHLORIDE)
55MG Marketing Status: Prescription

Active Ingredient: METHYLPHENIDATE HYDROCHLORIDE
Proprietary Name: ADHANSIA XR
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 55MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N212038
Product Number: 004
Approval Date: Feb 27, 2019
Applicant Holder Full Name: PURDUE PHARMA LP
Marketing Status:  Prescription
Patent and Exclusivity Information

ADHANSIA XR (METHYLPHENIDATE HYDROCHLORIDE)
70MG Marketing Status: Prescription

Active Ingredient: METHYLPHENIDATE HYDROCHLORIDE
Proprietary Name: ADHANSIA XR
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 70MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N212038
Product Number: 005
Approval Date: Feb 27, 2019
Applicant Holder Full Name: PURDUE PHARMA LP
Marketing Status:  Prescription
Patent and Exclusivity Information

ADHANSIA XR (METHYLPHENIDATE HYDROCHLORIDE)
85MG Marketing Status: Prescription

Active Ingredient: METHYLPHENIDATE HYDROCHLORIDE
Proprietary Name: ADHANSIA XR
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 85MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N212038
Product Number: 006
Approval Date: Feb 27, 2019
Applicant Holder Full Name: PURDUE PHARMA LP
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English